BioSpace News Archive

Johnson & Johnson today announced that the European Commission (EC) has granted Marketing Authorisation for its Janssen Pharmaceutical Companies’ Ebola vaccine regimen for the prevention of Ebola Virus Disease.

Photocure ASA (OSE:PHO), today announced the appointment of Susanne Strauss as Vice President and General Manager of Europe , effective 1 July 2020 . “I am pleased to welcome Susanne Strauss to the Photocure team and I am confident that Susanne’s background and experience will lend itself to the success launch of our European

EpicentRx Inc. (“EpicentRx”), a San Diego -based clinical cancer immunotherapy company and SciClone Pharmaceuticals International Ltd. , (“SciClone”) today announced that they have enter

Kroger Health’s new testing model combines at-home convenience with telehealth technology, with most results confirmed in less than 72 hours In partnership with Gravity Diagnostics, Kroger Health plans to process more than 60,000 tests per week by the end of July [01-July-2020] CINCINNATI , July 1, 2020 /PRNewswire/ -- Kroger Health, the healthcare division

Transcenta Holding Limited (“Transcenta”), a global biotherapeutics company with fully-integrated capabilities in discovery, development and manufacturing of antibody-based therapeutics, announced today that the first subject has been dosed successfully in the US Phase I clinical trial of TST001, a humanized Claudin18.2 (CLDN18.2) monoc

Amylyx Pharmaceuticals, Inc., a pharmaceutical company focused on developing new treatments for amyotrophic lateral sclerosis (ALS), Alzheimer’s disease and other neurodegenerative diseases, today announced it has closed an oversubscribed $30 mil

Ipsen presents Phase I/II clinical data evaluating liposomal irinotecan (Onivyde ® ) as an investigational first-line combination treatment for metastatic pancreatic cancer at the ESMO World Congress on Gastrointestinal Cancer Ipsen has initiated the NAPOLI-3 Phase III clinical study (NCT04083235) comparing the safety and efficacy of liposomal irinotecan + 5-fluorouracil/leucovorin (5-FU/LV) + oxaliplatin (OX) (NALIRIFOX) to gemcitabine + nab-paclitaxel in the f

scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced that it has resubmitted its 505(b)(2) New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) se

Battelle has directed philanthropic giving to the Columbus Urban League, Equal Justice Initiative and United Negro College Fund in the form of $100,000 gifts to each.

Sharps Compliance Corp., a leading full-service national provider of comprehensive waste management solutions including medical, pharmaceutical and hazardous, announced the appointment of Adrian W. Burke as Senior Vice President of Operations.